RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Pablo Vivas to Tumor Cells, Cultured

Back to Details
This is a "connection" page, showing publications Pablo Vivas has written about Tumor Cells, Cultured.
Pablo Vivas
Connection Strength
0.187
Tumor Cells, Cultured
  1. Echevarr?a-Vargas IM, Valiyeva F, Vivas-Mej?a PE. Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway. PLoS One. 2014; 9(5):e97094.
    View in: PubMed
    Score: 0.114
  2. Vivas-Mej?a PE, Cox O, Gonz?lez FA. Inhibition of human topoisomerase II by anti-neoplastic benzazolo[3,2-alpha]quinolinium chlorides. Mol Cell Biochem. 1998 Jan; 178(1-2):203-12.
    View in: PubMed
    Score: 0.037
  3. Vivas-Mej?a PE, Rodr?guez-Cab?n JL, D?az-Vel?zquez M, Hern?ndez-P?rez MG, Cox O, Gonzalez FA. DNA binding-independent anti-proliferative action of benzazolo[3,2-alpha]quinolinium DNA intercalators. Mol Cell Biochem. 1997 Dec; 177(1-2):69-77.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support